Clinical Perspectives on Bone Quality in Osteoporosis: Effects of Drug Therapy

Author： Licata Angelo A.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.24, Iss.7, 2007-01, pp. : 529-535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bone Morphogenetic Protein-Smad Pathway as Drug Targets for Osteoporosis and Cancer Therapy

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 3, 2008-09 ,pp. : 208-219

Bentham Science Publishers

Access to resources Recommend Favorite

High-Resolution Bone Imaging for Osteoporosis Diagnostics and Therapy Monitoring Using Clinical MDCT and MRI

By  

Current Medicinal Chemistry, Vol. 20, Iss. 38, 2013-12 ,pp. : 4844-4852

Bentham Science Publishers

Access to resources Recommend Favorite

New Clinical Perspectives of Hypolipidemic Drug Therapy in Severe Hypercholesterolemia

By  

Current Medicinal Chemistry, Vol. 19, Iss. 28, 2012-10 ,pp. : 4861-4868

Bentham Science Publishers

Access to resources Recommend Favorite

Zoledronic acid: an advance in tumour bone disease therapy and a new hope for osteoporosis

By Body Jean-Jacques  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 567-580

Informa Healthcare

Access to resources Recommend Favorite

Comprehensive Therapy in Osteoporosis Using a Single Drug: From ADFR to Strontium Ranelate

By  

Current Medicinal Chemistry, Vol. 13, Iss. 13, 2006-06 ,pp. : 1585-1590

Bentham Science Publishers

Access to resources Recommend Favorite